MedPath

Predictors of the Metabolic Effect of Sleep Loss

Not Applicable
Completed
Conditions
Apnea
Obstructive Sleep Apnea (OSA)
Obesity
Registration Number
NCT00965783
Lead Sponsor
University of Chicago
Brief Summary

To test whether baseline levels of slow wave activity (SWA) during sleep are lower in obese adults, and even lower in persons with sleep disordered breathing (SDB) compared to lean adults.

To compare levels of SWA in individuals in relation to their sleep time, blood pressure, heart rate, and markers of glucose metabolism.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • healthy,
  • normal sleepers,
  • lean, overweight,
  • obese,
  • pre menopausal
Exclusion Criteria
  • no shift workers or night-shift workers,
  • no mental health disorders,
  • no acute or chronic health conditions (stable, well controlled hypertension are accepted),
  • no hormonal treatments,
  • no substances that may interfere with sleep,
  • problems with sleep

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Correlation between SWA, sleep duration,sleep architecture, and biomarkers of the metabolic syndrome in lean, obese with and without obstructive sleep apnea.study completion
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The University of Chicago

🇺🇸

Chicago, Illinois, United States

The University of Chicago
🇺🇸Chicago, Illinois, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.